Rivaroxaban for 18 Months Versus 6 Months in Patients With Cancer and Acute Low-Risk Pulmonary Embolism: An Open-Label, Multicenter, Randomized Clinical Trial (ONCO PE Trial)

Yamashita Yugo; Morimoto Takeshi; Muraoka Nao; Shioyama Wataru; Chatani Ryuki; Shibata Tatsuhiro; Nishimoto Yuji; Ogihara Yoshito; Doi Kosuke; Oi Maki; Shiga Taro; Sueta Daisuke; Kim Kitae; Tanabe Yasuhiro; Koitabashi Norimichi; Takada Takuma; Ikeda Satoshi; Nakagawa Hitoshi; Tsukahara Kengo; Shoji Masaaki; Sakamoto Jiro; Hisatake Shinji; Ogino Yutaka; Fujita Masashi; Nakanishi Naohiko; Dohke Tomohiro; Hiramori Seiichi; Nawada Ryuzo; Kaneda Kazuhisa; Ono Koh; Kimura Takeshi,

WEKO3

lat lon distance

[[sub_check.contents]]

[[sub_radio.contents]]

Field does not validate

[[sub_attr.contents]]　

インデックスツリー

アイテム

Rivaroxaban for 18 Months Versus 6 Months in Patients With Cancer and Acute Low-Risk Pulmonary Embolism: An Open-Label, Multicenter, Randomized Clinical Trial (ONCO PE Trial)

https://marianna-u.repo.nii.ac.jp/records/2000939

名前 / ファイル	ライセンス	アクション
yamashita-et-al-rivaroxaban-for-18-months-versus-6-months-in-patients-with-cancer-and-acute-low-risk-pulmonary-embolism.pdf (1.2 MB)
cotr151_09_transcript.pdf (95 KB)
circ_circulationaha-2024-072758d_supp1.pdf (989 KB)
cotr151_09_master.mp3 (32 MB)
10.1161.circulationaha.124.072758 supplement.pdf (989 KB)

アイテムタイプ

学術雑誌掲載論文(1)

公開日

2025-10-08

タイトル

Rivaroxaban for 18 Months Versus 6 Months in Patients With Cancer and Acute Low-Risk Pulmonary Embolism: An Open-Label, Multicenter, Randomized Clinical Trial (ONCO PE Trial)

言語

eng

著者

Yamashita Yugo
Morimoto Takeshi
Muraoka Nao
Shioyama Wataru
Chatani Ryuki
Shibata Tatsuhiro
Nishimoto Yuji
Ogihara Yoshito
Doi Kosuke
Oi Maki
Shiga Taro
Sueta Daisuke
Kim Kitae
Tanabe Yasuhiro
Koitabashi Norimichi
Takada Takuma
Ikeda Satoshi
Nakagawa Hitoshi
Tsukahara Kengo
Shoji Masaaki
Sakamoto Jiro
Hisatake Shinji
Ogino Yutaka
Fujita Masashi
Nakanishi Naohiko
Dohke Tomohiro
Hiramori Seiichi
Nawada Ryuzo
Kaneda Kazuhisa
Ono Koh
Kimura Takeshi,

キーワード

言語

主題

anticoagulants, cardio-oncology, neoplasms, pulmonary embolism, recurrence, rivaroxaban

識別子

https://doi.org/10.1161/CIRCULATIONAHA.124.072758

識別子タイプ

DOI

書誌情報

en : Circulation

巻 151, 号 9, p. 589-600, ページ数 12, 発行日 2024-11-18

出版者

Lippincott Williams & Wilkins

言語

収録物識別子

収録物識別子タイプ

ISSN

収録物識別子

1524-4539

資源タイプ

資源タイプ識別子

http://purl.org/coar/resource_type/c_6501

資源タイプ

journal article

アクセス権

open access

権利情報

戻る

views

See details

	Views

Versions

Ver.1

2025-07-28 09:08:32.419176

Show All versions

Cite as

Other

エクスポート

OAI-PMH

JPCOAR 2.0
JPCOAR 1.0
DublinCore
DDI

Other Formats

メニューを最小化

インデックスリンク

インデックスツリー

アイテム

Rivaroxaban for 18 Months Versus 6 Months in Patients With Cancer and Acute Low-Risk Pulmonary Embolism: An Open-Label, Multicenter, Randomized Clinical Trial (ONCO PE Trial)

× Yamashita Yugo

× Morimoto Takeshi

× Muraoka Nao

× Shioyama Wataru

× Chatani Ryuki

× Shibata Tatsuhiro

× Nishimoto Yuji

× Ogihara Yoshito

× Doi Kosuke

× Oi Maki

× Shiga Taro

× Sueta Daisuke

× Kim Kitae

× Tanabe Yasuhiro

× Koitabashi Norimichi

× Takada Takuma

× Ikeda Satoshi

× Nakagawa Hitoshi

× Tsukahara Kengo

× Shoji Masaaki

× Sakamoto Jiro

× Hisatake Shinji

× Ogino Yutaka

× Fujita Masashi

× Nakanishi Naohiko

× Dohke Tomohiro

× Hiramori Seiichi

× Nawada Ryuzo

× Kaneda Kazuhisa

× Ono Koh

× Kimura Takeshi,

Versions

Share

Cite as

Other

エクスポート

コミュニティ